$AKOM
Aerkomm Inc. Stock $akom

$akom Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024040309 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue		$223.1K	$731.1K
YoY Change		-3776.11%
Cost Of Revenue	$22.73K	$1.339M	$1.811M
YoY Change
Gross Profit	-$22.73K	-$1.116M	-$1.080M
YoY Change		18279.24%
Gross Profit Margin		-499.96%	-147.7%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development		$36.71K	$1.308M
YoY Change		-93.08%	146.52%
% of Gross Profit
Depreciation & Amortization	$34.40K	$1.367M	$155.1K
YoY Change	-88.14%	369.15%	-85.5%
% of Gross Profit
Operating Expenses	$6.446M	$4.253M	$15.83M
YoY Change	77.31%	-2.22%	51.84%
Operating Profit	-$6.469M	-$5.368M	-$21.47M
YoY Change	77.93%	23.25%	105.95%
Interest Expense	-$447.6K	$982.9K	$1.627M
YoY Change	-117.21%	-0.33%	-199.34%
% of Operating Profit
Other Income/Expense, Net	-$442.6K	-$582.6K	6.820M jpies
YoY Change	-119.49%	155.88%	-1333.23%
Pretax Income	-$6.912M	-$9.529M	-$21.07M
YoY Change	406.53%	233.55%	77.43%
Income Tax		$0.00	$2.400K
% Of Pretax Income
Net Earnings	-$6.912M	-$9.529M	-$21.07M
YoY Change	405.64%	233.4%	77.41%
Net Earnings / Revenue		-4270.23%	-2882.54%
Basic Earnings Per Share	-$0.39		-$1.81
Diluted Earnings Per Share	-$0.39	-$0.56	-$1.81
COMMON SHARES
Basic Shares Outstanding	17.96M shares	9.869M shares	11.67M shares
Diluted Shares Outstanding	17.90M shares		11.67M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.156M	$8.008M	$8.008M
YoY Change	-81.17%	-9.9%	-9.9%
Cash & Equivalents	$78.50K	$7.429M
Short-Term Investments	$1.092M	$3.805M	$3.805M
Other Short-Term Assets	$69.23K	$65.94K	$224.1K
YoY Change	-95.36%	-99.18%	-97.22%
Inventory	$170.9K	$170.9K	$170.9K
Prepaid Expenses	$287.3K	$158.2K
Receivables	$0.00	$41.09K	$41.09K
Other Receivables	$2.337M	$122.0K	$1.290M
Total Short-Term Assets	$7.380M	$9.734M	$9.734M
YoY Change	-56.82%	-48.06%	-48.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$40.86M	$42.79M	$43.01M
YoY Change	10.87%	13.13%	13.71%
Goodwill	$4.574M	$4.574M
YoY Change	0.28%	0.28%
Intangibles	$12.14M	$13.02M
YoY Change	950.82%	828.68%
Long-Term Investments	$4.731M	$4.262M	$4.262M
YoY Change	12.91%	-6.79%	-6.79%
Other Assets	$27.79M	$5.837M	$5.837M
YoY Change	360.88%	-28.04%	-28.04%
Total Long-Term Assets	$73.38M	$79.03M	$79.03M
YoY Change	38.3%	52.28%	52.28%
TOTAL ASSETS
Total Short-Term Assets	$7.380M	$9.734M	$9.734M
Total Long-Term Assets	$73.38M	$79.03M	$79.03M
Total Assets	$80.76M	$88.77M	$88.77M
YoY Change	15.13%	25.66%	25.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.892M	$1.900M	$1.900M
YoY Change	10.87%	-2.59%	-2.59%
Accrued Expenses	$6.599M	$18.77M	$18.77M
YoY Change	-51.73%	634.97%	634.97%
Deferred Revenue	$762.0K
YoY Change
Short-Term Debt	$5.512M	$132.3K	$132.3K
YoY Change	314.0%	-89.95%	-89.95%
Long-Term Debt Due	$6.670K	$5.045K	$17.71K
YoY Change	-37.41%	-77.2%	-19.97%
Total Short-Term Liabilities	$58.70M	$28.08M	$28.08M
YoY Change	250.95%	125.38%	125.38%
LONG-TERM LIABILITIES
Long-Term Debt	$200.0K		$32.82M
YoY Change			1.53%
Other Long-Term Liabilities	$80.42K	$120.9K	$883.9K
YoY Change	-91.35%	-84.61%	12.52%
Total Long-Term Liabilities	$280.4K	$33.71M	$33.71M
YoY Change	-99.16%	1.79%	1.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$58.70M	$28.08M	$28.08M
Total Long-Term Liabilities	$280.4K	$33.71M	$33.71M
Total Liabilities	$58.98M	$61.79M	$61.79M
YoY Change	17.44%	35.58%	35.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$90.47M	-$74.72M
YoY Change	53.95%	39.28%
Common Stock	$18.20K	$16.72K
YoY Change	87.27%	72.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.78M	$26.98M	$26.98M
YoY Change
Total Liabilities & Shareholders Equity	$80.76M	$88.77M	$88.77M
YoY Change	15.13%	25.66%	25.66%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$6.912M	-$9.529M	-$21.07M
YoY Change	405.64%	233.4%	77.41%
Depreciation, Depletion And Amortization	$34.40K	$1.367M	$155.1K
YoY Change	-88.14%	369.15%	-85.5%
Cash From Operating Activities	-$2.304M	$7.895M	$522.7K
YoY Change	145.13%	-312.55%	-104.71%
INVESTING ACTIVITIES
Capital Expenditures	-$5.730K	$5.951M	$324.9K
YoY Change	-128.65%	359.52%	-75.14%
Acquisitions
YoY Change
Other Investing Activities	-$900.4K	$0.00	$325.6K
YoY Change		-100.0%	-122.35%
Cash From Investing Activities	-$894.7K	-$5.951M	-$6.005M
YoY Change	2882.33%	342.97%	117.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.053M	4.065M	$3.671M
YoY Change	-507.09%	-59.39%	-80.69%
NET CHANGE
Cash From Operating Activities	-2.304M	7.895M	$522.7K
Cash From Investing Activities	-894.7K	-5.951M	-$6.005M
Cash From Financing Activities	3.053M	4.065M	$3.671M
Net Change In Cash	-145.7K	6.009M	-$1.812M
YoY Change	-91.53%	21.3%	-135.18%
FREE CASH FLOW
Cash From Operating Activities	-$2.304M	$7.895M	$522.7K
Capital Expenditures	-$5.730K	$5.951M	$324.9K
Free Cash Flow	-$2.298M	$1.944M	$197.9K
YoY Change	139.43%	-138.8%	-101.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-55925
CY2023	dei	Entity Registrant Name EntityRegistrantName	AERKOMM INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3424568
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	44043 Fremont Blvd.
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
CY2023	dei	Entity Address Country EntityAddressCountry	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94538
CY2023	dei	City Area Code CityAreaCode	(877)
CY2023	dei	Local Phone Number LocalPhoneNumber	742-3094
CY2023	dei	Security12g Title Security12gTitle	Common Stock, $0.001 par value per share
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	23524331	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17962613	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	WWC, P.C.
CY2023	dei	Auditor Firm AuditorFirmId	1171
CY2023	dei	Auditor Location AuditorLocation	San Mateo, CA
CY2023Q4	us-gaap	Cash Cash	4202797	usd
CY2022Q4	us-gaap	Cash Cash	6878362	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	3804850	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	2009238	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	41088	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	170892	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1366282	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	158171	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	490044	usd
CY2023Q4	akom	Other Receivable Related Parties OtherReceivableRelatedParties	1167749	usd
CY2022Q4	akom	Other Receivable Related Parties OtherReceivableRelatedParties	308544	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	122024	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	119683	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	65937	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	32666	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9733508	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	11204819	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	4261920	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	4572243	usd
CY2023Q4	akom	Property Plant And Equipment Cost PropertyPlantAndEquipmentCost	5436657	usd
CY2022Q4	akom	Property Plant And Equipment Cost PropertyPlantAndEquipmentCost	4011883	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3085789	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2486836	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2350868	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1525047	usd
CY2023Q4	us-gaap	Land Land	40114286	usd
CY2022Q4	us-gaap	Land Land	35748435	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	324866	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	458998	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42790020	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37732480	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	2076138	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	8326017	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	7536409	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	3225905	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	3223558	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13024692	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1402500	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4573819	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4561037	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	221417	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	92451	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	534515	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	315015	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	31982503	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	17130970	usd
CY2023Q4	us-gaap	Assets Assets	88767951	usd
CY2022Q4	us-gaap	Assets Assets	70640512	usd
CY2022Q4	akom	Shortterm Loan Related Party ShorttermLoanRelatedParty	337357	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	132257	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	978896	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1900317	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1950939	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	5995972	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2433400	usd
CY2023Q4	akom	Other Payable Related Parties OtherPayableRelatedParties	726802	usd
CY2022Q4	akom	Other Payable Related Parties OtherPayableRelatedParties	340467	usd
CY2023Q4	akom	Other Payable Current OtherPayableCurrent	12617277	usd
CY2022Q4	akom	Other Payable Current OtherPayableCurrent	5017040	usd
CY2023Q4	akom	Prepayment From Customer Related Party PrepaymentFromCustomerRelatedParty	6534908	usd
CY2022Q4	akom	Prepayment From Customer Related Party PrepaymentFromCustomerRelatedParty	1258786	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5045	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11271	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	168433	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	131181	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28081011	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12459337	usd
CY2023Q4	us-gaap	Long Term Transition Bond LongTermTransitionBond	9648155	usd
CY2022Q4	us-gaap	Long Term Transition Bond LongTermTransitionBond	9137006	usd
CY2023Q4	akom	Convertible Longterm Note Payable ConvertibleLongtermNotePayable	23173200	usd
CY2022Q4	akom	Convertible Longterm Note Payable ConvertibleLongtermNotePayable	23173200	usd
CY2022Q4	akom	Lease Liability Noncurrent Related Party LeaseLiabilityNoncurrentRelatedParty	5027	usd
CY2023Q4	akom	Prepayments From Customer Noncurrent PrepaymentsFromCustomerNoncurrent	762000	usd
CY2022Q4	akom	Prepayments From Customer Noncurrent PrepaymentsFromCustomerNoncurrent	762000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	120932	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	35172	usd
CY2023Q4	akom	Restricted Stock Deposit Liability RestrictedStockDepositLiability	1000	usd
CY2022Q4	akom	Restricted Stock Deposit Liability RestrictedStockDepositLiability	1000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	33705287	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	33113405	usd
CY2023Q4	us-gaap	Liabilities Liabilities	61786298	usd
CY2022Q4	us-gaap	Liabilities Liabilities	45572742	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11672020	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11672020	shares
CY2023Q4	akom	Restricted Stock Shares RestrictedStockShares	149162	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9720003	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9720003	shares
CY2022Q4	akom	Restricted Stock Shares RestrictedStockShares	149162	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	16720	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	9720	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	97015470	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	79078005	usd
CY2023Q4	akom	Subscribed Capital SubscribedCapital	5004000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74719954	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53645981	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-334583	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-373974	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26981653	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	25067770	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	88767951	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	70640512	usd
CY2023	us-gaap	Revenues Revenues	731090	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1810876	usd
CY2023	us-gaap	Gross Profit GrossProfit	-1079786	usd
CY2023	akom	Operating Expenses Excluding Impairment Loss On Goodwill OperatingExpensesExcludingImpairmentLossOnGoodwill	15830119	usd
CY2022	akom	Operating Expenses Excluding Impairment Loss On Goodwill OperatingExpensesExcludingImpairmentLossOnGoodwill	10425183	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4560619	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-21470524	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-10425183	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1758264	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-50713	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-131214	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1587157	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	158355	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	740315	usd
CY2023	akom	Bond Issuance Cost BondIssuanceCost	511149	usd
CY2022	akom	Bond Issuance Cost BondIssuanceCost	483495	usd
CY2023	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-875305	usd
CY2022	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-69522	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	398951	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1450572	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21071573	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11875755	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2400	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2968	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-21073973	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11878723	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	39391	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1522184	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21034582	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10356539	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.8055
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.2036
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.8055
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.2036
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11672020	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9869165	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11672020	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9869165	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	34172276	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	32912	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1219121	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11878723	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1522184	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	25067770	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16493000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1444465	usd
CY2023	akom	Capital Injection CapitalInjection	5004000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-21073973	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	39391	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26981653	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-21073973	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11878723	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2264443	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1069692	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1444465	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1219121	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1758264	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-50713	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	511149	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	483495	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4560619	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	41088	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-136800	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1638240	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2461210	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3336327	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	859205	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	303954	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2341	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	118257	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	33271	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	22538	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	219500	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	192469	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-50622	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	397387	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3446193	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	108400	usd
CY2023	akom	Increase Decrease In Customer Advances And Deposit IncreaseDecreaseInCustomerAdvancesAndDeposit	5276122	usd
CY2022	akom	Increase Decrease In Customer Advances And Deposit IncreaseDecreaseInCustomerAdvancesAndDeposit	1258786	usd
CY2023	akom	Increase Decreasein Customer Advance IncreaseDecreaseinCustomerAdvance	-94634	usd
CY2023	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	386335	usd
CY2022	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	-353933	usd
CY2023	akom	Increase Decrease In Other Payable Others IncreaseDecreaseInOtherPayableOthers	7576034	usd
CY2022	akom	Increase Decrease In Other Payable Others IncreaseDecreaseInOtherPayableOthers	573895	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	16270	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-186337	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3041	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	522721	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11094249	usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	7823	usd
CY2023	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-325578	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	4237427	usd
CY2023	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1738705	usd
CY2022	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1306610	usd
CY2022	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	325578	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	354469	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1138952	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6005023	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2763317	usd
CY2023	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-1310600	usd
CY2022	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	182521	usd
CY2022	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	18849200	usd
CY2023	akom	Proceeds From Subscribed Capital ProceedsFromSubscribedCapital	5004000	usd
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	11253	usd
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	13090	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	11412	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	11927	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3670735	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19006704	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1811567	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5149138	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10101920	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3288813	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-861651	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1663969	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7428702	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10101920	usd
CY2023Q4	us-gaap	Cash Cash	4202797	usd
CY2022Q4	us-gaap	Cash Cash	6878362	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	3225905	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	3223558	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7428702	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10101920	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2400	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1600	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	14377.96	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	35232	usd
CY2023	akom	Acquisition Of Mesh AcquisitionOfMesh	16493000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	32912	usd
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.863	pure
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.997	pure
CY2022Q4	akom	Majority Interest MajorityInterest	25500000	shares
CY2022Q4	akom	Taiwan Buyer TaiwanBuyer	255000000	twd
CY2022	akom	Taiwan Buyer TaiwanBuyer	9023354	usd
CY2021Q4	akom	Working Capital WorkingCapital	4900000	usd
CY2023Q4	us-gaap	Bridge Loan BridgeLoan	10000000	usd
CY2023	akom	Aggregate Principal Amount aggregatePrincipalAmount	20000000	usd
CY2023	akom	Principal Loan Percentage PrincipalLoanPercentage	0.25	pure
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">Reclassifications of Prior Year Presentation </span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Certain prior year balance sheet, and cash flow statement amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">Use of Estimates</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results may differ from these estimates.</span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">Concentrations of Credit Risk</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash in banks. As of December 31, 2023 and 2022, the total balance of cash in bank exceeding the amount insured by the Federal Deposit Insurance Corporation (FDIC) for the Company was approximately $0 and $6,153,000, respectively. The balance of cash deposited in foreign financial institutions exceeding the amount insured by local insurance is approximately $7,246,000 and $3,134,000 as of December 31, 2023 and December 31, 2022, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">To minimize the credit risk of accounts receivable, the Company performs ongoing credit evaluation of its customers and requires no collateral. An allowance for doubtful accounts is provided based on a review of the collectability of accounts receivable. The Company determines the amount of allowance for doubtful accounts by examining its historical collection experience and current trends in the credit quality of its customers as well as its internal credit policies. Actual credit losses may differ from management’s estimates.</span></p>
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	0	usd
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	6153000	usd
CY2023	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	41088	usd
CY2022	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	0	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	usd
CY2023	akom	Translationadjustmentspolicytextblock Translationadjustmentspolicytextblock	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">Translation Adjustments</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If a foreign subsidiary’s functional currency is the local currency, translation adjustments will result from the process of translating the subsidiary’s financial statements into the reporting currency of the Company. Such adjustments are accumulated and reported under other comprehensive loss as a separate component of stockholders’ equity.</span></p>
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6482150	shares
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1993117	shares
CY2019Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	225500	usd
CY2019Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	200000	eur
CY2020Q4	akom	Dividends Shares Based Compensation Cash DividendsSharesBasedCompensationCash	20000	eur
CY2023Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	13831	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	6166	usd
CY2020Q4	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	6000000	shares
CY2020Q4	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	5027600	usd
CY2022Q3	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	35000000	twd
CY2022Q3	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	1138952	usd
CY2023Q4	akom	Investment Ejectt Shortterm InvestmentEjecttShortterm	2647975	usd
CY2022Q4	akom	Investment Ejectt Shortterm InvestmentEjecttShortterm	850182	usd
CY2023Q4	akom	Investment Liquidity InvestmentLiquidity	13831	usd
CY2022Q4	akom	Investment Liquidity InvestmentLiquidity	20104	usd
CY2023Q4	us-gaap	Prepaid Interest PrepaidInterest	1143044	usd
CY2022Q4	us-gaap	Prepaid Interest PrepaidInterest	1138952	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	3804850	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	2009238	usd
CY2023Q4	akom	Appreciation In Market Value AppreciationInMarketValue	2018757	usd
CY2022Q4	akom	Appreciation In Market Value AppreciationInMarketValue	223216	usd
CY2023Q4	akom	Investment Cost Ejectt Shortterm InvestmentCostEjecttShortterm	629218	usd
CY2022Q4	akom	Investment Cost Ejectt Shortterm InvestmentCostEjecttShortterm	626966	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	13831	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	20104	usd
CY2023Q4	akom	Prepaid Investment Cost PrepaidInvestmentCost	1143044	usd
CY2022Q4	akom	Prepaid Investment Cost PrepaidInvestmentCost	1138952	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	170892	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1366282	usd
CY2023Q4	akom	Prepaid Professional Expense PrepaidProfessionalExpense	110043	usd
CY2022Q4	akom	Prepaid Professional Expense PrepaidProfessionalExpense	79954	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	48128	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	410090	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	158171	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	490044	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	2076138	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	8326017	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	7536409	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	10402155	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	7536409	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	158171	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	490044	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	2076138	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	8326017	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	7536409	usd
CY2022Q4	akom	Property Plant And Equipment Cost PropertyPlantAndEquipmentCost	4011883	usd
CY2023	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	1430045	usd
CY2023	akom	Property Plant And Equipment Cta PropertyPlantAndEquipmentCTA	-5271	usd
CY2023Q4	akom	Property Plant And Equipment Cost PropertyPlantAndEquipmentCost	5436657	usd
CY2023Q4	akom	Property Plant And Equipment Cost PropertyPlantAndEquipmentCost	5436657	usd
CY2022Q4	akom	Property Plant And Equipment Cost PropertyPlantAndEquipmentCost	4011883	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	324866	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	458998	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2486836	usd
CY2023	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	602438	usd
CY2023	akom	Accumulated Depreciation Depletion And Amortization Cta On Property And Equipment AccumulatedDepreciationDepletionAndAmortizationCTAOnPropertyAndEquipment	-3485	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3085789	usd
CY2023	us-gaap	Depreciation Depreciation	601618	usd
CY2022	us-gaap	Depreciation Depreciation	563399	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	40050000	twd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	1303287	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	10005000	twd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	325578	usd
CY2022Q4	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	667000	shares
CY2023Q4	akom	Investment Cost Ejectt Longterm InvestmentCostEjecttLongterm	-4261920	usd
CY2022Q4	akom	Investment Cost Ejectt Longterm InvestmentCostEjecttLongterm	-4246665	usd
CY2022Q4	akom	Investment Cost Ana Navi Tek InvestmentCostAnaNaviTek	-325578	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	4261920	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	4572243	usd
CY2023	akom	Accumulated Impairment Addition AccumulatedImpairmentAddition	4561037	usd
CY2021Q4	akom	Finite Lived Intangible Asset Net FiniteLivedIntangibleAssetNet	1897500	usd
CY2022	akom	Additional Accumulated Amortization Intangible Asset AdditionalAccumulatedAmortizationIntangibleAsset	495000	usd
CY2022Q4	akom	Finite Lived Intangible Asset Net FiniteLivedIntangibleAssetNet	1402500	usd
CY2023	akom	Additional Accumulated Amortization Intangible Asset AdditionalAccumulatedAmortizationIntangibleAsset	-11622192	usd
CY2023Q4	akom	Finite Lived Intangible Asset Net FiniteLivedIntangibleAssetNet	13024692	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	834277	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	495000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1740647	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1658147	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1245647	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1245647	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1245647	usd
CY2023Q3	akom	Ownership Percentage OwnershipPercentage	1	pure
CY2023Q3	us-gaap	Shares Issued SharesIssued	7000448	shares
CY2023Q3	us-gaap	Share Price SharePrice	2.36
CY2023Q3	akom	Acquisition Cost AcquisitionCost	11926181	usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	4573819	usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	1475334	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1475334	usd
CY2022	akom	Goodwill Addition GoodwillAddition	3085703	usd
CY2022	akom	Goodwill Addition Net GoodwillAdditionNet	3085703	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	4561037	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4561037	usd
CY2023	akom	Goodwill Addition GoodwillAddition	4573819	usd
CY2023	akom	Goodwill Addition Net GoodwillAdditionNet	12782	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	9134856	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	4561037	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4573819	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	4561037	usd
CY2022	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	0	usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	4561037	usd
CY2023	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	4573819	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y11M19D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0382	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0382	pure
CY2023Q4	akom	Current Lease Liability Operating Leases CurrentLeaseLiabilityOperatingLeases	155764	usd
CY2022Q4	akom	Current Lease Liability Operating Leases CurrentLeaseLiabilityOperatingLeases	120323	usd
CY2023Q4	akom	Current Lease Liability Finance Lease CurrentLeaseLiabilityFinanceLease	12669	usd
CY2022Q4	akom	Current Lease Liability Finance Lease CurrentLeaseLiabilityFinanceLease	10858	usd
CY2023Q4	akom	Total Current Lease Liability TotalCurrentLeaseLiability	168433	usd
CY2022Q4	akom	Total Current Lease Liability TotalCurrentLeaseLiability	131181	usd
CY2023Q4	akom	Current Lease Liability Others CurrentLeaseLiabilityOthers	168433	usd
CY2022Q4	akom	Current Lease Liability Others CurrentLeaseLiabilityOthers	131181	usd
CY2023Q4	akom	Noncurrent Lease Liability Operating Leases NoncurrentLeaseLiabilityOperatingLeases	120932	usd
CY2022Q4	akom	Noncurrent Lease Liability Operating Leases NoncurrentLeaseLiabilityOperatingLeases	22548	usd
CY2022Q4	akom	Noncurrent Lease Liability Finance Leases NoncurrentLeaseLiabilityFinanceLeases	12624	usd
CY2023Q4	akom	Noncurrent Lease Liability NoncurrentLeaseLiability	120932	usd
CY2022Q4	akom	Noncurrent Lease Liability NoncurrentLeaseLiability	35172	usd
CY2023Q4	akom	Noncurrent Lease Liability Others NoncurrentLeaseLiabilityOthers	120932	usd
CY2022Q4	akom	Noncurrent Lease Liability Others NoncurrentLeaseLiabilityOthers	35172	usd
CY2023	akom	Lease Expense LeaseExpense	130250	usd
CY2022	akom	Lease Expense LeaseExpense	152922	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	8546	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	81177	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	121704	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	71744	usd
CY2023	akom	Finance Lease Amortization Of Property And Equipment FinanceLeaseAmortizationOfPropertyAndEquipment	-10903	usd
CY2022	akom	Finance Lease Amortization Of Property And Equipment FinanceLeaseAmortizationOfPropertyAndEquipment	-11396	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	699	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1150	usd
CY2023	akom	Total Finance Lease Cost TotalFinanceLeaseCost	11602	usd
CY2022	akom	Total Finance Lease Cost TotalFinanceLeaseCost	12545	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	93841	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	125501	usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	10713	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	10777	usd
CY2023	akom	Financing Cash Outflows From Finance Lease FinancingCashOutflowsFromFinanceLease	699	usd
CY2022	akom	Financing Cash Outflows From Finance Lease FinancingCashOutflowsFromFinanceLease	1150	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	74795	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	110735	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	89256	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	37190	usd
CY2023	akom	Totaloperating Lease Payments TotaloperatingLeasePayments	237181	usd
CY2023	akom	Lessoperating Imputed Interest LessoperatingImputedInterest	-15763	usd
CY2023	akom	Present Value Of Finance Lease Liabilities PresentValueOfFinanceLeaseLiabilities	221418	usd
CY2023Q4	akom	Operating Lease Liability Related Party And Others Current Portion OperatingLeaseLiabilityRelatedPartyAndOthersCurrentPortion	-100486	usd
CY2023Q4	akom	Operating Lease Liabilities Noncurrent OperatingLeaseLiabilitiesNoncurrent	120932	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	12939	usd
CY2023	us-gaap	Lease Income LeaseIncome	12939	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	269	usd
CY2023	akom	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	12669	usd
CY2023Q4	us-gaap	Net Investment In Lease Current NetInvestmentInLeaseCurrent	12669	usd
CY2021Q2	akom	Loan Agreement In The Amount LoanAgreementInTheAmount	1433177	usd
CY2021Q2	akom	Loan Agreement In The Amount LoanAgreementInTheAmount	40000000	twd
CY2021Q2	akom	Agreed Shares AgreedShares	3000000	shares
CY2023Q4	akom	Repaid Outstanding Loan RepaidOutstandingLoan	930521	usd
CY2023Q4	akom	Repaid Outstanding Loan RepaidOutstandingLoan	30000000	twd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	1500000	twd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	48988	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	48812	usd
CY2023	akom	Line Of Credit Facility Expiration Date LineOfCreditFacilityExpirationDate	2024-05-21
CY2023	akom	Line Of Credit Facility Commitments Fee Percentage LineOfCreditFacilityCommitmentsFeePercentage	0.097	pure
CY2023	akom	Installment Payment Description InstallmentPaymentDescription	The installment payment plan is 60 months to pay off the balance on the 21st of each month.
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5168	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5168	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Imputed Interest UnrecordedUnconditionalPurchaseObligationImputedInterest	123	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	5045	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5045	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	1074	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	3338	usd
CY2020Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	200000	usd
CY2020Q4	akom	Interest Of Percentage InterestOfPercentage	0.075	pure
CY2023	akom	Redemptions Of Debt Description RedemptionsOfDebtDescription	The Company has the option to redeem the Bonds at a redemption amount equal to the Early Redemption Amount, as defined in the Offering Memorandum, at any time on or after December 2, 2023 and prior to the Maturity Date, if the Closing Price of the Company’s Common Stock listed on the Euronext Paris for 20 trading days in any period of 30 consecutive trading days, the last day of which occurs not more than fifteen trading days prior to the date on which notice of such redemption is given, is greater than 130% of the Conversion Price on each applicable trading day or (ii) in whole or in part of the Bonds on the second anniversary of the issue date or (iii) where 90% or more in principal amount of the Bonds issued have been redeemed, converted or repurchased and cancelled.
CY2020Q4	akom	Common Stock Convertible Par Or Stated Value Per Share CommonStockConvertibleParOrStatedValuePerShare	0.001
CY2023	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	13.3
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3068385	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10200000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10200000	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	551845	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	1062994	usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	9648155	usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	9137006	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	511149	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	483496	usd
CY2022Q2	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	3175200	usd
CY2022	akom	Deferred Costs Gross Other DeferredCostsGrossOther	-35932	usd
CY2022Q3	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	5674000	usd
CY2022Q4	akom	Common Stock Total Subscriptions Value CommonStockTotalSubscriptionsValue	13173200	usd
CY2023Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	10000000	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	30000000	usd
CY2023Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.04	pure
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	6
CY2015Q1	akom	Purchase Agreement Terms PurchaseAgreementTerms	P10Y
CY2015Q1	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	909000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2400	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1600	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1368	usd
CY2023	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	2400	usd
CY2022	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	2968	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2850860	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2941489	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2776874	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1650091	usd
CY2023	akom	Stockbased Compensation Expense StockbasedCompensationExpense	303300	usd
CY2022	akom	Stockbased Compensation Expense StockbasedCompensationExpense	256000	usd
CY2023	akom	Accrued Payroll AccruedPayroll	-316500	usd
CY2022	akom	Accrued Payroll AccruedPayroll	103600	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-428590	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	737056	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	155100	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	79700	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-269224	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	361142	usd
CY2023	akom	Deferred Costs Gross Other DeferredCostsGrossOther	-700	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2400	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2968	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14831000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10694000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3502000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3098000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	889000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	412000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	68000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	68000	usd
CY2023Q4	akom	Excess Of Tax Amortization Over Book Amortization ExcessOfTaxAmortizationOverBookAmortization	-285000	usd
CY2022Q4	akom	Excess Of Tax Amortization Over Book Amortization ExcessOfTaxAmortizationOverBookAmortization	-344000	usd
CY2023Q4	akom	Unrealized Exchanges Losses UnrealizedExchangesLosses	20000	usd
CY2022Q4	akom	Unrealized Exchanges Losses UnrealizedExchangesLosses	311000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	27000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-97000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19052000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14142000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19052000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14142000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4910000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1579000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1802373	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1802373	shares
CY2023	akom	Share Based Compensation Arrangement By Sharebased Payment Award Option Nonvested Number Of Shares ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionNonvestedNumberOfShares	149162	shares
CY2022	akom	Share Based Compensation Arrangement By Sharebased Payment Award Option Nonvested Number Of Shares ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionNonvestedNumberOfShares	149162	shares
CY2023	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1951535	shares
CY2022	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1951535	shares
CY2023	akom	Total Sales Percentage TotalSalesPercentage	0.10	pure
CY2023Q4	us-gaap	Investment Sold Not Yet Purchased Percent Of Net Assets InvestmentSoldNotYetPurchasedPercentOfNetAssets	0.10	pure
CY2022Q4	us-gaap	Investment Sold Not Yet Purchased Percent Of Net Assets InvestmentSoldNotYetPurchasedPercentOfNetAssets	0.10	pure
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P2Y
CY2023	us-gaap	Other Expenses OtherExpenses	6820000	jpy
CY2022	us-gaap	Other Expenses OtherExpenses	51800	usd
CY2023Q4	akom	Sales Agreements SalesAgreements	1243247	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	20000000	twd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	653168	usd
CY2023Q4	us-gaap	Equipment Expense EquipmentExpense	4330592	usd
CY2023Q4	us-gaap	Equipment Expense EquipmentExpense	5333333	twd
CY2023Q4	us-gaap	Equipment Expense EquipmentExpense	174178	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	2076138	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	59021	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1807000	twd
CY2023Q4	akom	Loans And Lease Receivable Net Reported Amount LoansAndLeaseReceivableNetReportedAmount	956835	usd
CY2021	akom	Consulting Fees ConsultingFees	15120	eur
CY2021	akom	Consulting Fees ConsultingFees	17000	usd
CY2023Q4	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	75327	usd
CY2023Q4	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	2306000	twd
CY2023	akom	Purchase From Ejectt PurchaseFromEjectt	457976	usd
CY2023	akom	Connection Service Income From Ejectt ConnectionServiceIncomeFromEjectt	117419	usd
CY2023	akom	Other Income From Ejectt OtherIncomeFromEjectt	45543	usd
CY2023	akom	Other Income From Others OtherIncomeFromOthers	10682	usd
CY2023	akom	Nonoperating Service Income From Star Jec NonoperatingServiceIncomeFromStarJec	2757	usd
CY2022	akom	Nonoperating Service Income From Star Jec NonoperatingServiceIncomeFromStarJec	5904	usd
CY2023	akom	Rental Income From Mepa RentalIncomeFromMepa	8546	usd
CY2022	akom	Rental Income From Mepa RentalIncomeFromMepa	9119	usd
CY2023	akom	Rent Expense From Ejectt RentExpenseFromEjectt	2858	usd
CY2023	us-gaap	Aircraft Rental And Landing Fees AircraftRentalAndLandingFees	100000	jpy
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	293000	twd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	9800	usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	1350612	twd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	48346	usd
	us-gaap	Other Income OtherIncome	10865	usd
CY2017Q2	akom	Vest Rate Percentage VestRatePercentage	0.50	pure
CY2017Q3	us-gaap	Shares Acquired Weighted Average Discount To Net Assets Percentage SharesAcquiredWeightedAverageDiscountToNetAssetsPercentage	0.50	pure
CY2017Q4	akom	Independent Directors Shares IndependentDirectorsShares	4000	shares
CY2018Q4	akom	Independent Directors Shares IndependentDirectorsShares	4000	shares
CY2019Q4	akom	Aggregate Shares AggregateShares	85400	shares
CY2019Q4	akom	Vest Rate Percentage VestRatePercentage	0.25	pure
CY2021Q4	akom	Vest Rate Percentage VestRatePercentage	0.25	pure
CY2020Q4	akom	Vest Rate Percentage VestRatePercentage	0.25	pure
CY2022Q4	akom	Vest Rate Percentage VestRatePercentage	0.25	pure
CY2019Q4	akom	Independent Directors Shares IndependentDirectorsShares	4000	shares
CY2021Q1	akom	Independent Directors Shares IndependentDirectorsShares	4000	shares
CY2021Q4	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2021Q4	akom	Stock Option Aggregate Shares StockOptionAggregateShares	8000	shares
CY2021Q4	akom	Stock Option Aggregate Share StockOptionAggregateShare	4000	shares
CY2021Q4	akom	Stock Option Aggregate Shares StockOptionAggregateShares	2000	shares
CY2022Q1	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2022Q3	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2018Q3	akom	Stock Option Aggregate Shares StockOptionAggregateShares	4000	shares
CY2022Q4	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2022Q4	akom	Stock Option Aggregate Shares StockOptionAggregateShares	8000	shares
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	4000	shares
CY2023Q1	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2023Q2	akom	Stock Option Aggregate Shares StockOptionAggregateShares	786356	shares
CY2023Q2	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2023Q2	akom	Stock Option Aggregate Shares StockOptionAggregateShares	3627679	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1444465	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1219121	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1207897	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.2537
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.5309
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	162000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.1566
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.332
CY2022	akom	Number Of Shares Forfeited Cancelledin Shares NumberOfSharesForfeitedCancelledinShares	-90209	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	11.9003
CY2022	akom	Weighted Average Fair Value Per Share Forfeited Cancelled Per Shares WeightedAverageFairValuePerShareForfeitedCancelledPerShares	8.3775
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1279688	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.8161
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.3194
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	805103	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.5605
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.9779
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2084791	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.6279
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.2566
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	40194	shares
CY2021Q4	akom	Sharebased Compensations Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	8.9422
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	162000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.332
CY2022	akom	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Vested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesVested	-183194	shares
CY2022	akom	Average Granted Date Fair Value Vestedin Dollars Per Share AverageGrantedDateFairValueVestedinDollarsPerShare	6.7206
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	8000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	14.4305
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	11000	shares
CY2022Q4	akom	Sharebased Compensations Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.507
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	805103	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.9779
CY2023	akom	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Vested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesVested	-144426	shares
CY2023	akom	Average Granted Date Fair Value Vestedin Dollars Per Share AverageGrantedDateFairValueVestedinDollarsPerShare	2.1351
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	671677	shares
CY2023Q4	akom	Sharebased Compensations Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.9691
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	2.58
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	2.89
CY2022Q4	us-gaap	Option Indexed To Issuers Equity Settlement Alternatives Shares At Fair Value OptionIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue	25500000	shares
CY2022Q4	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase	255000000	twd
CY2022Q4	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase	8300000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent		usd
CY2023Q4	akom	Shortterm Loan Related Party ShorttermLoanRelatedParty		usd
CY2023Q4	akom	Lease Liability Noncurrent Related Party LeaseLiabilityNoncurrentRelatedParty		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	akom	Subscribed Capital SubscribedCapital		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2022	akom	Increase Decreasein Customer Advance IncreaseDecreaseinCustomerAdvance		usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		usd
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2023	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2023	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
CY2022	akom	Proceeds From Subscribed Capital ProceedsFromSubscribedCapital		usd
CY2022	akom	Acquisition Of Mesh AcquisitionOfMesh		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent		usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent		usd
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals		usd
CY2023	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1		usd
CY2023Q4	akom	Investment Cost Ana Navi Tek InvestmentCostAnaNaviTek		usd
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2022	akom	Accumulated Impairment Addition AccumulatedImpairmentAddition		usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2023Q4	akom	Current Lease Liability Related Parties CurrentLeaseLiabilityRelatedParties		usd
CY2022Q4	akom	Current Lease Liability Related Parties CurrentLeaseLiabilityRelatedParties		usd
CY2023Q4	akom	Noncurrent Lease Liability Finance Leases NoncurrentLeaseLiabilityFinanceLeases		usd
CY2023Q4	akom	Noncurrent Lease Liability Related Parties NoncurrentLeaseLiabilityRelatedParties		usd
CY2022Q4	akom	Noncurrent Lease Liability Related Parties NoncurrentLeaseLiabilityRelatedParties		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q4	us-gaap	Net Investment In Lease Noncurrent NetInvestmentInLeaseNoncurrent		usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo		usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2022	akom	Purchase From Ejectt PurchaseFromEjectt		usd
CY2022	akom	Connection Service Income From Ejectt ConnectionServiceIncomeFromEjectt		usd
CY2022	akom	Other Income From Ejectt OtherIncomeFromEjectt		usd
CY2022	akom	Other Income From Others OtherIncomeFromOthers		usd
CY2023	akom	Interest Expense Charged By Wtl InterestExpenseChargedByWTL		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
CY2023	akom	Number Of Shares Forfeited Cancelledin Shares NumberOfSharesForfeitedCancelledinShares		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023	akom	Weighted Average Fair Value Per Share Forfeited Cancelled Per Shares WeightedAverageFairValuePerShareForfeitedCancelledPerShares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001590496
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
0001213900-24-040309-index-headers.html	Edgar Link	pending
0001213900-24-040309-index.html	Edgar Link	pending
0001213900-24-040309.txt	Edgar Link	pending
0001213900-24-040309-xbrl.zip	Edgar Link	pending
akom-20231231.xsd	Edgar Link	pending
ea0203967-10k_aerkomm.htm	Edgar Link	pending
ea020396701ex10-85_aerkomm.htm	Edgar Link	pending
akom-20231231_cal.xml	Edgar Link	unprocessable
akom-20231231_lab.xml	Edgar Link	unprocessable
akom-20231231_pre.xml	Edgar Link	unprocessable
ea0203967-10k_aerkomm_htm.xml	Edgar Link	completed
ea020396701ex21-1_aerkomm.htm	Edgar Link	pending
ea020396701ex31-1_aerkomm.htm	Edgar Link	pending
ea020396701ex31-2_aerkomm.htm	Edgar Link	pending
ea020396701ex32-1_aerkomm.htm	Edgar Link	pending
ea020396701ex32-2_aerkomm.htm	Edgar Link	pending
ea020396701ex4-3_aerkomm.htm	Edgar Link	pending
ea020396701ex4-4_aerkomm.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
image_017.jpg	Edgar Link	pending
image_018.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
akom-20231231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AKOM
Aerkomm Inc. Stock $akom

2024 Q2 Form 10-K Financial Statement

#000121390024040309 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKOM Aerkomm Inc. Stock $akom

2024 Q2 Form 10-K Financial Statement

#000121390024040309 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKOM
Aerkomm Inc. Stock $akom